View in EDS

214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor.

Saved in:
Bibliographic Details
Title: 214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor.
Authors: Fons, P.1 (AUTHOR), Gomez-Roca, C.A.2 (AUTHOR), Cassier, P.3 (AUTHOR), Delord, J-P.2 (AUTHOR), Rochaix, P.4 (AUTHOR), Korakis, I.5 (AUTHOR), Leonardi, G.C.6 (AUTHOR), Hanvic, B.7 (AUTHOR), Tsoutzidis, N.8 (AUTHOR), Davenne, L.9 (AUTHOR), Mandron, M.10 (AUTHOR), Corsi, A.11 (AUTHOR), Verlingue, L.12 (AUTHOR), Meca, C.C.13 (AUTHOR), Fitzgerald, M.14 (AUTHOR), Friend, J.15 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS290-S291. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189418491
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fons%2C+P%2E%22">Fons, P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2EA%2E%22">Gomez-Roca, C.A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cassier%2C+P%2E%22">Cassier, P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Delord%2C+J-P%2E%22">Delord, J-P.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rochaix%2C+P%2E%22">Rochaix, P.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Korakis%2C+I%2E%22">Korakis, I.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leonardi%2C+G%2EC%2E%22">Leonardi, G.C.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hanvic%2C+B%2E%22">Hanvic, B.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tsoutzidis%2C+N%2E%22">Tsoutzidis, N.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Davenne%2C+L%2E%22">Davenne, L.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mandron%2C+M%2E%22">Mandron, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Corsi%2C+A%2E%22">Corsi, A.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verlingue%2C+L%2E%22">Verlingue, L.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meca%2C+C%2EC%2E%22">Meca, C.C.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fitzgerald%2C+M%2E%22">Fitzgerald, M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Friend%2C+J%2E%22">Friend, J.</searchLink><relatesTo>15</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS290-S291. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189418491
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.646
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S290
    Titles:
      – TitleFull: 214eP Exploratory biomarkers evaluation to enhance characterization and explore treatment response prediction in metastatic ovarian cancer patients undergoing therapy with EVT801, a highly selective VEGFR-3 inhibitor.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fons, P.
      – PersonEntity:
          Name:
            NameFull: Gomez-Roca, C.A.
      – PersonEntity:
          Name:
            NameFull: Cassier, P.
      – PersonEntity:
          Name:
            NameFull: Delord, J-P.
      – PersonEntity:
          Name:
            NameFull: Rochaix, P.
      – PersonEntity:
          Name:
            NameFull: Korakis, I.
      – PersonEntity:
          Name:
            NameFull: Leonardi, G.C.
      – PersonEntity:
          Name:
            NameFull: Hanvic, B.
      – PersonEntity:
          Name:
            NameFull: Tsoutzidis, N.
      – PersonEntity:
          Name:
            NameFull: Davenne, L.
      – PersonEntity:
          Name:
            NameFull: Mandron, M.
      – PersonEntity:
          Name:
            NameFull: Corsi, A.
      – PersonEntity:
          Name:
            NameFull: Verlingue, L.
      – PersonEntity:
          Name:
            NameFull: Meca, C.C.
      – PersonEntity:
          Name:
            NameFull: Fitzgerald, M.
      – PersonEntity:
          Name:
            NameFull: Friend, J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1